These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3826723)

  • 61. [Malignant hyperthermia--now a controllable potentially lethal anesthesia complication].
    Schulte-Sasse U; Eberlein HJ
    Dtsch Med Wochenschr; 1981 Oct; 106(43):1405-8. PubMed ID: 7285820
    [No Abstract]   [Full Text] [Related]  

  • 62. Malignant hyperthermia: current perspectives.
    Felice-Johnson J; Sudds T; Bennett G
    Am J Hosp Pharm; 1981 May; 38(5):646-51. PubMed ID: 7282692
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Readiness for malignant hyperthermia can be survey stumbling block.
    Traynor K
    Am J Health Syst Pharm; 2016 Jun; 73(12):852-3. PubMed ID: 27261225
    [No Abstract]   [Full Text] [Related]  

  • 64. [Dantrolene. Pharmacological and therapeutic aspects].
    Gerbershagen MU; Fiege M; Krause T; Agarwal K; Wappler F
    Anaesthesist; 2003 Mar; 52(3):238-45. PubMed ID: 12666006
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment of porcine malignant hyperpyrexia. The successful use of dantrolene in the Pietrain pig.
    Hall GM; Lucke JN; Lister D
    Anaesthesia; 1977 May; 32(5):472-4. PubMed ID: 869147
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cocaine.
    Kaukonen L; Hoffman RS
    N Y State J Med; 1990 Jan; 90(1):39. PubMed ID: 2328049
    [No Abstract]   [Full Text] [Related]  

  • 67. [An original technic for the preparation of an injectable solution of sodium dantrolene from oral capsules (Dantralen) or from the pure substance].
    de Pascual Mettler I; Borrego Dionis AM; González Machado JL
    Rev Esp Anestesiol Reanim; 1985; 32(4):166-8. PubMed ID: 4048581
    [No Abstract]   [Full Text] [Related]  

  • 68. [Dantrolen solution of high active substance concentration. Preliminary communication (author's transl)].
    Rommelsheim K; Lauven P; Westhofen P; Stenger I; Stoeckel H
    Anasth Intensivther Notfallmed; 1980 Oct; 15(5):423-7. PubMed ID: 6779658
    [TBL] [Abstract][Full Text] [Related]  

  • 69. When economy meets medicine--malignant hyperthermia in Taiwan.
    Sun WZ; Yeh HM
    Acta Anaesthesiol Taiwan; 2004 Sep; 42(3):125-6. PubMed ID: 15551888
    [No Abstract]   [Full Text] [Related]  

  • 70. [Malignant hyperthermia. II. Investigation of the patient's family (author's transl)].
    Plötz J
    Anaesthesist; 1980 Feb; 29(2):94-8. PubMed ID: 7377529
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Malignant hyperthermia.
    Gallagher DM
    Oral Surg Oral Med Oral Pathol; 1979 Nov; 48(5):415. PubMed ID: 290941
    [No Abstract]   [Full Text] [Related]  

  • 72. Effects of azumolene on normal and malignant hyperthermia-susceptible skeletal muscle.
    Sudo RT; Carmo PL; Trachez MM; Zapata-Sudo G
    Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):308-16. PubMed ID: 18047479
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effective use of dantrolene in a patient susceptible to malignant hyperthermia.
    Gallagher DM; Hyer RL
    J Oral Surg; 1980 Jun; 38(6):438-40. PubMed ID: 6929328
    [No Abstract]   [Full Text] [Related]  

  • 74. [Malignant hyperthermia--a hereditary and potentially life-threatening condition].
    Haugen T; Toft M; Müller CR; Aasly J
    Tidsskr Nor Laegeforen; 2005 Oct; 125(20):2792-4. PubMed ID: 16244682
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [A case of malignant hyperthermia without hyperthermia].
    Muiños PA; Ortells MA; Sánchez G; Carrasco MS
    Rev Esp Anestesiol Reanim; 1995 Dec; 42(10):436. PubMed ID: 8789530
    [No Abstract]   [Full Text] [Related]  

  • 76. Malignant hyperpyrexia.
    Isaacs H
    S Afr Med J; 1977 Aug; 52(10):387-8. PubMed ID: 897843
    [No Abstract]   [Full Text] [Related]  

  • 77. [Recently registered drugs in Belgium].
    Harvengt C
    Acta Clin Belg; 1981; 36(1):53-5. PubMed ID: 7293641
    [No Abstract]   [Full Text] [Related]  

  • 78. [Treatment of malignant hyperthermia by dantrolene sodium administered through a nasogastric tube].
    Nagase M; Naganuma Y; Ryo K; Sato N; Kawashima Y
    Masui; 1984 Sep; 33(9):1021-6. PubMed ID: 6512969
    [No Abstract]   [Full Text] [Related]  

  • 79. Malignant hyperthermia.
    Jordan LM
    Todays OR Nurse; 1987 Apr; 9(4):12-8. PubMed ID: 3647678
    [No Abstract]   [Full Text] [Related]  

  • 80. Treatment of neuroleptic malignant syndrome with dantrolene.
    Goekoop JG; Carbaat PA
    Lancet; 1982 Jul; 2(8288):49-50. PubMed ID: 6123782
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.